Zach Hornby, Boundless CEO
April 28, 2021 07:36 AM EDTUpdated 03:04 PM
Financing

Bound­less Bio rais­es $105M in ef­fort to reimag­ine tar­get­ed can­cer ther­a­py

Jason Mast

Editor

Bound­less Bio CEO Zach Horn­by was sit­ting in his La Jol­la, CA of­fice last fall, prepar­ing for a board meet­ing when his com­put­er pinged with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times